Type I angiotensin II receptor specific monoclonal antibodies and hybridomas
US6063620A · kind A · utility
5Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 1996 |
| Grant date | May 16, 2000 |
| Priority date | — |
| Expiry date | Mar 27, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel hybridoma cell line which secretes monoclonal antibodies capable of binding to the AT.sub.1 subtype of the Angiotensin II receptor. It also relates to monoclonal antibodies secreted by the hybridoma, which antibodies may be used in diagnostic test kits as well as having therapeutic applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.